We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eagle Eye Solutions Group Plc | LSE:EYE | London | Ordinary Share | GB00BKF1YD83 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 465.00 | 460.00 | 470.00 | 465.00 | 465.00 | 465.00 | 2,004 | 07:31:04 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Computer Programming Service | 47.93M | 5.73M | 0.1936 | 24.02 | 137.7M |
From Dec 2019 to Dec 2024
Sales of Abbott's coronary stents - which are used to prop open damaged arteries - rose 124.5% to $410 million.
(In =UPDATE: Abbott 4Q Net Up 28% On Xience, Humira Sales Growth," published at 11:13 a.m. EST, the sales figure was incorrect)
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary. You can use this link on the day this article is published and the following day.
1 Year Eagle Eye Solutions Chart |
1 Month Eagle Eye Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
